Predicting the Safety and Effectiveness of Inferior Vena Cava Filters

The PRESERVE Trial is the first large-scale, multi-specialty, prospective clinical study to evaluate the use of inferior vena cava (IVC) filters and related follow-up treatment in the United States.

It is sponsored by IVC Filter Study Group Foundation, which is a joint collaboration between the Society of Interventional Radiology (SIR) and the Society for Vascular Surgery (SVS).

Learn More

Predicting the Safety and Effectiveness of Inferior Vena Cava Filters

The PRESERVE Trial is the first large-scale, multi-specialty, prospective clinical study to evaluate the use of inferior vena cava (IVC) filters and related follow-up treatment in the United States.

It is sponsored by IVC Filter Study Group Foundation, which is a joint collaboration between the Society of Interventional Radiology (SIR) and the Society for Vascular Surgery (SVS).

Learn More

The Latest from PRESERVE

News

As of March 2019, PRESERVE is closed to new patient enrollment.

For Patients

If you are considering participating or already enrolled in PRESERVE »

Important information about PRESERVE.

The Latest from PRESERVE

News

As of March 2019, PRESERVE is closed to new patient enrollment.

News

Predicting the Safety and Effectiveness of Inferior Vena Cava Filters Study: Design of a unique safety and effectiveness study of inferior vena cava filters in clinical practice was published in the Journal of Vascular Surgery: Venous and Lymphatic Disorders in October 2019.

For Patients

If you are considering participating or already enrolled in PRESERVE »

Important information about PRESERVE.